Hong Zhang

机构：Wannan Medical College, Central South University of Forestry and Technology, Beijing Institute of Technology, Beijing Tongren Hospital, Central South University, Xinjiang Medical University, Harbin Medical University, Bristol-Myers Squibb (Germany), China Three Gorges University, Hunan Normal University, Anhui Medical University, Brookhaven National Laboratory, Peking University, First Affiliated Hospital of Xinjiang Medical University, Bristol-Myers Squibb (United States), Qinhuangdao Second Hospital, Qinhuangdao Science and Technology Bureau, Peking University First Hospital, Tianjin Chest Hospital, First Affiliated Hospital of Harbin Medical University, Second Affiliated Hospital of Zhejiang University, Shanxi Academy of Medical Sciences, Cixian People's Hospital, Qinhuangdao Vocational and Technical College, Lanzhou University · ORCID：0000-0002-0430-2319

发表论文 172 篇 · 总被引 1954 次 · h-index 22

代表论文

• Discovery of BMS-986408, a First-In-Class Dual DGKα and DGKζ Inhibitor that Unleashes PD-1 Checkpoint and CAR T-cell Immunotherapies (2025 · Cancer Immunology Research · 被引 9)
• AI assistance enhances histopathologic distinction between sebaceous and squamous cell carcinoma of the eyelid (2025 · npj Digital Medicine · 被引 5)
• Involvement of TMAO in exacerbating arsenic-induced neurotoxicity by activating the PERK/eIF2α/ATF4 pathway (2025 · Ecotoxicology and Environmental Safety · 被引 3)
• Ternary Alloy Pt₅(Ce)-Co Multi-Layered Intermetallic Nanoparticles As Highly Active Catalysts for the Oxygen Reduction Reaction in Pemfcs (2025 · ECS Meeting Abstracts)
• Biomarker Insights from the Phase 3 APPLAUSE-IgAN Study: Iptacopan's Proteomic Signature in IgAN (2025 · Journal of the American Society of Nephrology)
• Author response: Oxytocin restores context-specific hyperaltruistic preference (2025)